Literature DB >> 27264984

Inhibition of LPS-induced inflammatory mediators by 3-hydroxyanthranilic acid in macrophages through suppression of PI3K/NF-κB signaling pathways.

Kyoungran Lee1, Jong-Hwan Kwak1, Suhkneung Pyo1.   

Abstract

Many tryptophan metabolites have immunomodulatory effects on various immune cells. 3-Hydroxyanthranilic Acid (3-HAA) is a tryptophan metabolite reported to have anti-inflammatory activity. The mechanism of this activity is unclear. The present study examined the immunomodulatory effects and molecular mechanisms of 3-HAA on macrophages. Pretreatment of 3-HAA (0.1-10 μg mL(-1)) for 2 h markedly inhibited NO and cytokine production in LPS-stimulated Raw 264.7 cells. Moreover, translocation and activation of NF-κB by LPS in the nucleus were abrogated through the prevention of IκB degradation by 3-HAA treatment. 3-HAA significantly suppressed LPS-induced PI3K/Akt/mTOR activation, whereas MAPKs were not affected by 3-HAA treatment. Furthermore, the inhibition of mTOR by 3-HAA resulted in decreased production of inflammatory mediators and NF-κB activity. Similar results were also observed in primary peritoneal macrophages. Furthermore, 3-HAA modulated macrophage polarization. Collectively, the results suggest that 3-HAA has an immunomodulatory effect that may result from inhibition of PI3K/Akt/mTOR and NF-κB activation, thereby decreasing the production of pro-inflammatory mediators.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27264984     DOI: 10.1039/c6fo00187d

Source DB:  PubMed          Journal:  Food Funct        ISSN: 2042-6496            Impact factor:   5.396


  12 in total

1.  Hederacoside-C Inhibition of Staphylococcus aureus-Induced Mastitis via TLR2 & TLR4 and Their Downstream Signaling NF-κB and MAPKs Pathways In Vivo and In Vitro.

Authors:  Muhammad Akhtar; Aftab Shaukat; Arshad Zahoor; Yu Chen; Ying Wang; Mei Yang; Talha Umar; Mengyao Guo; Ganzhen Deng
Journal:  Inflammation       Date:  2020-04       Impact factor: 4.092

Review 2.  Tryptophan-derived serotonin-kynurenine balance in immune activation and intestinal inflammation.

Authors:  Sabah Haq; Jensine A Grondin; Waliul I Khan
Journal:  FASEB J       Date:  2021-10       Impact factor: 5.834

3.  PI3K inhibition protects mice from NAFLD by down-regulating CMKLR1 and NLRP3 in Kupffer cells.

Authors:  Wenfeng Zhang; Yan Liu; Mingbing Wu; Xiwen Zhu; Tao Wang; Kun He; Peizhi Li; Xiaoling Wu
Journal:  J Physiol Biochem       Date:  2017-09-13       Impact factor: 4.158

Review 4.  Kynurenine pathway, NAD+ synthesis, and mitochondrial function: Targeting tryptophan metabolism to promote longevity and healthspan.

Authors:  Raul Castro-Portuguez; George L Sutphin
Journal:  Exp Gerontol       Date:  2020-01-16       Impact factor: 4.032

Review 5.  Anti-Inflammatory Activity of Natural Products.

Authors:  Abdullatif Azab; Ahmad Nassar; Abed N Azab
Journal:  Molecules       Date:  2016-10-01       Impact factor: 4.411

6.  The Gut Microbiome and Metabolites Are Altered and Interrelated in Patients With Rheumatoid Arthritis.

Authors:  Die Yu; Juping Du; Xia Pu; Liyuan Zheng; Shuaishuai Chen; Na Wang; Jun Li; Shiyong Chen; Shaobiao Pan; Bo Shen
Journal:  Front Cell Infect Microbiol       Date:  2022-01-25       Impact factor: 5.293

Review 7.  Targeting regulation of tryptophan metabolism for colorectal cancer therapy: a systematic review.

Authors:  Hong-Lian Zhang; Ai-Hua Zhang; Jian-Hua Miao; Hui Sun; Guang-Li Yan; Fang-Fang Wu; Xi-Jun Wang
Journal:  RSC Adv       Date:  2019-01-23       Impact factor: 4.036

Review 8.  Not Only Immune Escape-The Confusing Role of the TRP Metabolic Pathway in Carcinogenesis.

Authors:  Iwona Kwiatkowska; Justyna Magdalena Hermanowicz; Alicja Przybyszewska-Podstawka; Dariusz Pawlak
Journal:  Cancers (Basel)       Date:  2021-05-28       Impact factor: 6.639

9.  3-Hydroxyanthralinic acid metabolism controls the hepatic SREBP/lipoprotein axis, inhibits inflammasome activation in macrophages, and decreases atherosclerosis in Ldlr-/- mice.

Authors:  Martin Berg; Konstantinos A Polyzos; Hanna Agardh; Roland Baumgartner; Maria J Forteza; Ilona Kareinen; Anton Gisterå; Gerhard Bottcher; Eva Hurt-Camejo; Göran K Hansson; Daniel F J Ketelhuth
Journal:  Cardiovasc Res       Date:  2020-10-01       Impact factor: 10.787

10.  Comprehensive assessment of multiple tryptophan metabolites as potential biomarkers for immune checkpoint inhibitors in patients with non-small cell lung cancer.

Authors:  M Karayama; J Masuda; K Mori; H Yasui; H Hozumi; Y Suzuki; K Furuhashi; T Fujisawa; N Enomoto; Y Nakamura; N Inui; T Suda; M Maekawa; H Sugimura; A Takada
Journal:  Clin Transl Oncol       Date:  2020-06-12       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.